Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Ampio Climbs on Study of Ampion for Knee Pain

By Pharmaceutical Processing | August 14, 2013

Shares of Ampio Pharmaceuticals Inc. jumped Wednesday after the company said its drug Ampion reduced knee pain caused by osteoarthritis in a recent study.

The company said people injected with Ampion had a 40-percent reduction in pain on average, and the drug was more effective than a saline injection. Ampio also said the patients treated with Ampion had a greater improvement in knee function compared to patients who received the saline injection.

Ampio shares climbed 90 cents, or 16.8 percent, to $6.26 in midday trading, after spiking as high as $6.99 earlier in the session.

The late-stage trial compared two doses of Ampion, and Ampio said there wasn’t a significant difference in their effectiveness. Ampio will consult with the Food and Drug Administration on the preferred dose for another late-stage study.

The Greenwood Village, Colo., company does not have any approved drugs. It is also testing a premature ejaculation and impotence drug called Zertane and an eye drug called Optina.

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE